Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4+ T cells and decreases their susceptibility to apoptosis in vitro and in vivo

Blood

Volumn 94, Issue 3, 1999, Pages 1021-1027

  Sloand, Elaine M ^a   Kumar, Princy N ^b   Kim, Sonnie ^b   Chaudhuri, Aniruddho ^b   Weichold, Frank F ^b   Young, Neal S ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GANCICLOVIR; INDINAVIR; INTERLEUKIN 1BETA CONVERTING ENZYME; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME INHIBITION; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

EID: 0033179343     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.1021.415k29_1021_1027     Document Type: Article

References (27)

1. Sloand EM, Maciejewski JP, Tadatsugu S, Bruny J, Kumar P, Kim S: The role of inlerleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J Clin Invest 101:195, 1998
2. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA: Interleukin-1 β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med 186:1365, 1997
3. + T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists. Blood 87:4959, 1996
4. Oyaizu N, Pahwa S: Role of apoptosis in HIV pathogenesis. J Clin Immunol 15:217, 1995
5. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331, 1992
6. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710, 1991
7. + lymphocyte depletion and human immunodeficiency virus replication. Blood 89:1357, 1997
8. Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Keuz W, Benner A, Krammer PH: High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children, Blood 83:3101, 1994
9. Radrizzani M, Accomero P, Deliz D, Kurrle R, Colombo MP: Apoptosis induced by HIV-gp120 in a Th1 clone involves the generation of reactive oxygen intermediates downstream CD95 triggering. FEBS Lett 411:87, 1997
10. Maciejewski JP, Weichold FF, Young NS: HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 153:4303, 1994
11. Accornero P, Radrizzani M, Delia D, Gerosa F, Kurrle R, Columbo MP: Differential susceptibility to HIV GP120 sensitized apoptosis in CD4+ T cell clones with different T-helper pheontypes: Role of CD95/CD95L interactions. Blood 89:558, 1997
12. Okada H, Takei R, Tashiro M: HIV-1 Nef protein-induced apoptosis cytolysis of a broad spectrum of uninfected human blood cells independently of CD95 (Fas). FEBS Lett 414:603, 1997
13. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonazlez C, McMahon D, Richmand DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA: Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 337:734, 1997
14. Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Kravick S, Maurath, C, Sun E, Henry D, Rhode R, Potthoff A, Leonard J: Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 351:543, 1998
15. Bohler T, Herr I, Debatin KM, Geiss M, Haas J: Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy. Blood 90:886, 1997
16. Sander B, Andersson J, Andersson U: Assessment of cytokines by immunofluorescence and the paraformaldehyde saponin procedure. Immunol Rev 119:65, 1991
17. Martin SJ, Amarante-Mendes GP, Shi L, Chuang TS, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH, Green DR: The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J 15:2407, 1996
18. Roberts NA, Craid JC, Sheldon J: Resistance and cross-resistance with saquinavir and other HIV protease inhibitors theory and practice. AIDS 12:453, 1998
19. Flexner C: HIV-protease inhibitors. N Engl J Med 338:1281, 1998
20. Cohen J: AIDS therapy. Failure isn't what it use to be. . .but neither is success (news). Science 279:1133, 1998
21. Ghandi RT, Chenk BK, Straus SE, Dale JK, Lenardo MJ: Baltimore, HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med 187:1113, 1998
22. Borthwick NJ, Wickremasinghe RG, Lewin J, Fairbanks LD, Bofil M: Activation-associated necrosis in human immunodeficiency virus infection. J Infect Dis 179:352, 1999
23. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T: Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 11:1287, 1998
24. Jeremias I, Heir I, Boehler T, Debatin KM: TRAIL/Apo-2 ligand induced apoptosis in human T cellls. Eur J Immunol 28:143, 1998
25. Chinnaiyan AM, Woffendin C, Dixit VM, Nabel GJ: The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication. Nate Med 3:333, 1997
26. Clem RJ, Miller LK: Apoptosis reduces both the in vitro replication and the in vivo infectivity of a baculovirus. J Virol 67:3730, 1993
27. Clouston WM, Kerr JFR: Apoptosis, lymphocytotoxicity and the containment of viral infections. Med Hypoth 18:399, 1985